Editorial Board
Editor-in-Chief
Aung Naing, MD, FACP
Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Editorial Board Members
Jibran Ahmed, MD
Assistant Research Physician, Developmental Therapeutics Clinic, National Cancer Institute, National Institutes of Health, Bethesda, MD
Karen Autio, MD, MSc
Assistant Attending, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Helen Chen, MD
Senior Investigator and Medical Officer, Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program (CTEP), National Cancer Institute, Bethesda, MD, USA
Ecaterina Dumbrava, MD
Assistant Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Gerald Falchook, MD, MS
Director, Drug Development Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA
Joud Hajjar, MD, PhD, MS
Associate Professor and Service Chief, Adult Allergy and Immunology, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA
Rebecca Harrison, MD
Clinical Associate Professor, Division of Neurology, University of British Columbia; BC Cancer, Vancouver, BC, Canada
Sungjune Kim, MD, PhD
Vice Chair of Research and Director of Preclinical & Translational Research, Department of Radiation Oncology, Mayo Clinic Alix College of Medicine & Health Sciences, Jacksonville, FL, USA
Matthew Krebs, MD
Clinical Senior Lecturer, Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester; Consultant in Medical Oncology, Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK
Yisheng Li, PhD
Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Chia-Chi Lin, MD, PhD
Director of Phase 1 Center, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
Sewanti Limaye MS, MBBS, MD
Department of Clinical and Translational Research Oncology, Department of Precision Oncology, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India
Herbert Loong, MD
Clinical Associate Professor, Department of Clinical Oncology; Deputy Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
Juanita Lopez, MD
Consultant in Medical Oncology, Drug Development Phase 1 Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK
Christophe Massard, MD
Department of Drug Development (DITEP), Gustave Roussy, Villejuif, France
Gil Morgan, MD
Department of Oncology, Skåne University Hospital, Lund, Sweden
Mirella Nardo, MD
Faculty of Clinical Oncology, ICESP – Instituto do Cancer do Estado de Sao Paulo; Rede D'Or, SP, Brazil
Haeseong Park, MD MPH
Associate Professor of Medicine, Gastrointestinal Cancer Center, Center for Cancer Therapeutic Innovation, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Naveen Pemmaraju, MD
Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Jordi Rodon, MD
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Christian Rolfo, MD
Associate Director of Clinical Research, Center for Thoracic Oncology, The Tisch Cancer Institute, Mount Sinai Health System; Professor, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Patricia Roxburgh, MBChB, FRCP, PhD
Professor, Experimental Cancer Medicine, Honorary Consultant Medical Oncologist, University of Glasgow School of Cancer Sciences; Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK
Ajay Sheshadri, MD
Associate Professor, Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Bettzy Stephen, MD
Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Eddy Yang, MD, PhD
Professor and Markey Cancer Foundation Chair, Department of Radiation Medicine, Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA
